Skip to content
TrialScanner

NCT03439072

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Phase 3CompletedXERSLead

Registry record

Lead sponsor
Xeris Pharmaceuticals
Conditions
Insulin Hypoglycemia; Type 1 Diabetes Mellitus; Severe Hypoglycemia
Primary completion
Apr 18, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03439072 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03439072: G-Pen™ Compared to Lilly... | TrialScanner